| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IGM Biosciences, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 170,061 | $216,453 | $1.27 | 23 Jul 2025 | Direct |
| Maze Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 325,000 | 02 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 02 Sep 2025 | 1 | $0 | 4 | Chief Financial Officer | 02 Sep 2025, 18:30 |
| MAZE | Maze Therapeutics, Inc. | 02 Sep 2025 | 0 | $0 | 3 | Chief Financial Officer | 02 Sep 2025, 18:29 |
| IGMS | IGM Biosciences, Inc. | 23 Jul 2025 | 1 | -$11,126 | 4 | CHIEF FINANCIAL OFFICER | 25 Jul 2025, 19:06 |
| IGMS | IGM Biosciences, Inc. | 16 Jun 2025 | 1 | -$1,825 | 4 | CHIEF FINANCIAL OFFICER | 20 Jun 2025, 20:23 |
| IGMS | IGM Biosciences, Inc. | 14 Mar 2025 | 1 | -$9,015 | 4 | CHIEF FINANCIAL OFFICER | 18 Mar 2025, 19:09 |
| IGMS | IGM Biosciences, Inc. | 16 Dec 2024 | 1 | -$12,776 | 4 | CHIEF FINANCIAL OFFICER | 18 Dec 2024, 19:10 |
| IGMS | IGM Biosciences, Inc. | 18 Nov 2024 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 20 Nov 2024, 17:36 |
| IGMS | IGM Biosciences, Inc. | 13 Sep 2024 | 1 | -$17,158 | 4 | CHIEF FINANCIAL OFFICER | 17 Sep 2024, 20:54 |
| IGMS | IGM Biosciences, Inc. | 19 Jul 2024 | 4 | $0 | 4 | CHIEF FINANCIAL OFFICER | 23 Jul 2024, 20:42 |
| IGMS | IGM Biosciences, Inc. | 14 Jun 2024 | 1 | -$11,893 | 4 | CHIEF FINANCIAL OFFICER | 18 Jun 2024, 19:43 |
| IGMS | IGM Biosciences, Inc. | 13 Mar 2024 | 2 | -$54,472 | 4 | CHIEF FINANCIAL OFFICER | 15 Mar 2024, 19:53 |
| IGMS | IGM Biosciences, Inc. | 12 Mar 2024 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 14 Mar 2024, 18:22 |
| IGMS | IGM Biosciences, Inc. | 27 Nov 2023 | 2 | -$4,024 | 4 | Chief Financial Officer | 29 Nov 2023, 20:49 |
| IGMS | IGM Biosciences, Inc. | 23 May 2023 | 3 | -$10,836 | 4 | Chief Financial Officer | 25 May 2023, 19:23 |
| IGMS | IGM Biosciences, Inc. | 04 Apr 2023 | 2 | $0 | 4 | Chief Financial Officer | 06 Apr 2023, 21:45 |
| IGMS | IGM Biosciences, Inc. | 14 Mar 2023 | 1 | -$33,118 | 4 | Chief Financial Officer | 16 Mar 2023, 18:30 |
| IGMS | IGM Biosciences, Inc. | 16 Dec 2022 | 3 | -$119,359 | 4 | Chief Financial Officer | 20 Dec 2022, 19:09 |
| IGMS | IGM Biosciences, Inc. | 23 Nov 2022 | 3 | -$14,385 | 4 | Chief Financial Officer | 28 Nov 2022, 19:31 |
| IGMS | IGM Biosciences, Inc. | 26 May 2022 | 1 | -$16,247 | 4 | Chief Financial Officer | 26 May 2022, 16:48 |
| IGMS | IGM Biosciences, Inc. | 13 May 2022 | 1 | +$4,841 | 4 | Chief Financial Officer | 17 May 2022, 19:00 |
| IGMS | IGM Biosciences, Inc. | 15 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 17 Mar 2022, 18:42 |
| IGMS | IGM Biosciences, Inc. | 12 Mar 2022 | 2 | $0 | 4 | Chief Financial Officer | 15 Mar 2022, 20:54 |
| IGMS | IGM Biosciences, Inc. | 15 Nov 2021 | 1 | $0 | 4 | Chief Financial Officer | 19 Nov 2021, 19:36 |
| IGMS | IGM Biosciences, Inc. | 15 Nov 2021 | 1 | +$4,385 | 4 | Chief Financial Officer | 17 Nov 2021, 17:50 |
| IGMS | IGM Biosciences, Inc. | 14 May 2021 | 1 | +$2,066 | 4 | Chief Financial Officer | 18 May 2021, 21:42 |